Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576407 · ClinicalTrials.gov registry record · Phase 2
Thymus Transplantation in DiGeorge Syndrome #668
A Phase 2 study, sponsored by Sumitomo Pharma Switzerland.
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
NCT00576407 is a Phase 2 study that has completed, run by Sumitomo Pharma Switzerland. The registered enrollment target is 26 participants.
The verdict
NCT00576407, a Phase 2 study, has completed, sponsored by Sumitomo Pharma Switzerland.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
Study Summary
The study purpose is to determine whether cultured thymus tissue implantation (CTTI) is effective in treating typical complete DiGeorge syndrome.
Interventions
- BIOLOGICAL Cultured Thymus Tissue for Implantation (CTTI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 1991-10 |
| Est. Completion | 2017-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00576407
The ClinicalTrials.gov registry entry for NCT00576407 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sumitomo Pharma Switzerland, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cultured Thymus Tissue for Implantation (CTTI) is the first listed.
NCT00576407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00576407 about?
NCT00576407 is a clinical study titled "Thymus Transplantation in DiGeorge Syndrome #668". The study purpose is to determine whether cultured thymus tissue implantation (CTTI) is effective in treating typical complete DiGeorge syndrome.
What is the current status of trial NCT00576407?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 1991-10. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT00576407?
The interventions under investigation include: Cultured Thymus Tissue for Implantation (CTTI) (BIOLOGICAL).
Who is sponsoring clinical trial NCT00576407?
This trial is sponsored by Sumitomo Pharma Switzerland, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.